

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 9.57485936 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 9.57485936 |
| 3 | angiotensin maturation (GO:0002003) | 8.77201199 |
| 4 | regulation of guanylate cyclase activity (GO:0031282) | 8.42931266 |
| 5 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 7.56985022 |
| 6 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 6.94666391 |
| 7 | positive regulation of guanylate cyclase activity (GO:0031284) | 6.64421020 |
| 8 | endocrine pancreas development (GO:0031018) | 6.39117080 |
| 9 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 6.30566748 |
| 10 | peptide hormone processing (GO:0016486) | 6.28927192 |
| 11 | positive regulation of insulin secretion (GO:0032024) | 6.26720349 |
| 12 | COPII vesicle coating (GO:0048208) | 6.00619569 |
| 13 | NADH metabolic process (GO:0006734) | 5.92913578 |
| 14 | intestinal absorption (GO:0050892) | 5.89631668 |
| 15 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 5.87396942 |
| 16 | glandular epithelial cell differentiation (GO:0002067) | 5.77957943 |
| 17 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 5.75735099 |
| 18 | negative regulation of execution phase of apoptosis (GO:1900118) | 5.70267151 |
| 19 | protein retention in ER lumen (GO:0006621) | 5.69790467 |
| 20 | L-alpha-amino acid transmembrane transport (GO:1902475) | 5.56302612 |
| 21 | positive regulation of pseudopodium assembly (GO:0031274) | 5.33078167 |
| 22 | positive regulation of vesicle fusion (GO:0031340) | 5.31148156 |
| 23 | epoxygenase P450 pathway (GO:0019373) | 5.22216550 |
| 24 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.19107252 |
| 25 | positive regulation of peptide hormone secretion (GO:0090277) | 5.11755184 |
| 26 | regulation of cGMP biosynthetic process (GO:0030826) | 5.11163163 |
| 27 | positive regulation of amino acid transport (GO:0051957) | 5.08924817 |
| 28 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.06858302 |
| 29 | diacylglycerol metabolic process (GO:0046339) | 5.06494920 |
| 30 | positive regulation of respiratory burst (GO:0060267) | 5.02868358 |
| 31 | regulation of cellular extravasation (GO:0002691) | 4.93495560 |
| 32 | positive regulation of peptide secretion (GO:0002793) | 4.93299729 |
| 33 | signal peptide processing (GO:0006465) | 4.84798091 |
| 34 | antibacterial humoral response (GO:0019731) | 4.81671297 |
| 35 | regulation of pseudopodium assembly (GO:0031272) | 4.77953439 |
| 36 | antimicrobial humoral response (GO:0019730) | 4.77837366 |
| 37 | fructose metabolic process (GO:0006000) | 4.73092615 |
| 38 | positive regulation of peptidyl-threonine phosphorylation (GO:0010800) | 4.61227567 |
| 39 | hormone catabolic process (GO:0042447) | 4.58828553 |
| 40 | regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178) | 4.58806943 |
| 41 | glandular epithelial cell development (GO:0002068) | 4.57129741 |
| 42 | regulation of insulin secretion (GO:0050796) | 4.47974069 |
| 43 | regulation of systemic arterial blood pressure (GO:0003073) | 4.47946172 |
| 44 | epithelial cell fate commitment (GO:0072148) | 4.43520386 |
| 45 | glycine transport (GO:0015816) | 4.42207316 |
| 46 | insulin secretion (GO:0030073) | 4.41699163 |
| 47 | peptide catabolic process (GO:0043171) | 4.37883967 |
| 48 | type B pancreatic cell development (GO:0003323) | 4.36918438 |
| 49 | lipoprotein transport (GO:0042953) | 4.35820285 |
| 50 | toxin metabolic process (GO:0009404) | 4.32084767 |
| 51 | drug metabolic process (GO:0017144) | 4.30947583 |
| 52 | regulation of bile acid biosynthetic process (GO:0070857) | 4.30032367 |
| 53 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.29223221 |
| 54 | regulation of cGMP metabolic process (GO:0030823) | 4.23349621 |
| 55 | response to dietary excess (GO:0002021) | 4.22937339 |
| 56 | negative regulation of JUN kinase activity (GO:0043508) | 4.21499831 |
| 57 | vesicle coating (GO:0006901) | 4.19464302 |
| 58 | growth hormone secretion (GO:0030252) | 4.18839442 |
| 59 | detection of calcium ion (GO:0005513) | 4.13760294 |
| 60 | sequestering of metal ion (GO:0051238) | 4.13188183 |
| 61 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 4.12633019 |
| 62 | adhesion of symbiont to host cell (GO:0044650) | 4.10703773 |
| 63 | virion attachment to host cell (GO:0019062) | 4.10703773 |
| 64 | regulation of peptide hormone secretion (GO:0090276) | 4.09787913 |
| 65 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 4.08473083 |
| 66 | cellular response to vitamin D (GO:0071305) | 4.06594581 |
| 67 | regulation of peptide secretion (GO:0002791) | 4.01680751 |
| 68 | vitamin transport (GO:0051180) | 3.99121051 |
| 69 | renal system process involved in regulation of blood volume (GO:0001977) | 3.95806843 |
| 70 | glycolipid catabolic process (GO:0019377) | 3.94395163 |
| 71 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.93412260 |
| 72 | glycosphingolipid catabolic process (GO:0046479) | 3.92155996 |
| 73 | positive regulation of hormone secretion (GO:0046887) | 3.91584179 |
| 74 | positive regulation of histone H3-K4 methylation (GO:0051571) | 3.91164402 |
| 75 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.88005124 |
| 76 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.83642007 |
| 77 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.82132356 |
| 78 | urea cycle (GO:0000050) | 3.81841752 |
| 79 | protein autoprocessing (GO:0016540) | 3.78124392 |
| 80 | positive regulation of calcium ion import (GO:0090280) | 3.77997742 |
| 81 | transcytosis (GO:0045056) | 3.76194502 |
| 82 | arginine metabolic process (GO:0006525) | 3.76078518 |
| 83 | peptide hormone secretion (GO:0030072) | 3.75968064 |
| 84 | astrocyte differentiation (GO:0048708) | 3.74642676 |
| 85 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.73666892 |
| 86 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.71297464 |
| 87 | positive regulation of nuclease activity (GO:0032075) | 3.70397594 |
| 88 | peptide secretion (GO:0002790) | 3.66386726 |
| 89 | urea metabolic process (GO:0019627) | 3.61937195 |
| 90 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.61230600 |
| 91 | regulation of respiratory burst (GO:0060263) | 3.60060361 |
| 92 | eosinophil chemotaxis (GO:0048245) | 3.59827160 |
| 93 | bile acid and bile salt transport (GO:0015721) | 3.59001704 |
| 94 | cGMP-mediated signaling (GO:0019934) | 3.57584822 |
| 95 | regulation of glucocorticoid secretion (GO:2000849) | 3.57213699 |
| 96 | regulation of hormone secretion (GO:0046883) | 3.56521345 |
| 97 | vitamin transmembrane transport (GO:0035461) | 3.55888392 |
| 98 | negative regulation of digestive system process (GO:0060457) | 3.54976770 |
| 99 | positive regulation of gluconeogenesis (GO:0045722) | 3.54444984 |
| 100 | glomerular filtration (GO:0003094) | 3.53560693 |
| 101 | regulation of vitamin metabolic process (GO:0030656) | 3.53409633 |
| 102 | uronic acid metabolic process (GO:0006063) | 3.52521245 |
| 103 | glucuronate metabolic process (GO:0019585) | 3.52521245 |
| 104 | drug catabolic process (GO:0042737) | 3.51389346 |
| 105 | cellular glucuronidation (GO:0052695) | 3.50286721 |
| 106 | ER to Golgi vesicle-mediated transport (GO:0006888) | 3.49597724 |
| 107 | adhesion of symbiont to host (GO:0044406) | 3.49209782 |
| 108 | glutathione biosynthetic process (GO:0006750) | 3.48715384 |
| 109 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.48376715 |
| 110 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.48143300 |
| 111 | * digestion (GO:0007586) | 3.47081010 |
| 112 | cellular response to cadmium ion (GO:0071276) | 3.46940334 |
| 113 | protein maturation by protein folding (GO:0022417) | 3.46414756 |
| 114 | intra-Golgi vesicle-mediated transport (GO:0006891) | 3.46159417 |
| 115 | cobalamin metabolic process (GO:0009235) | 3.40214363 |
| 116 | neuron fate specification (GO:0048665) | 3.38850627 |
| 117 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.37458363 |
| 118 | endocrine process (GO:0050886) | 3.37458363 |
| 119 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.37458363 |
| 120 | protein localization to Golgi apparatus (GO:0034067) | 3.36977306 |
| 121 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.36852731 |
| 122 | oligosaccharide biosynthetic process (GO:0009312) | 3.35895411 |
| 123 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.35732785 |
| 124 | cellular response to zinc ion (GO:0071294) | 3.35174079 |
| 125 | regulation of nuclease activity (GO:0032069) | 3.35139267 |
| 126 | exogenous drug catabolic process (GO:0042738) | 3.34517767 |
| 127 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.33927918 |
| 128 | genitalia morphogenesis (GO:0035112) | 3.32999425 |
| 129 | glycosylceramide metabolic process (GO:0006677) | 3.31992798 |
| 130 | nitrogen cycle metabolic process (GO:0071941) | 3.30345526 |
| 131 | columnar/cuboidal epithelial cell development (GO:0002066) | 3.30131173 |
| 132 | ER overload response (GO:0006983) | 3.29739377 |
| 133 | regulation of corticosteroid hormone secretion (GO:2000846) | 3.28155449 |
| 134 | regulation of triglyceride catabolic process (GO:0010896) | 3.26403286 |
| 135 | glycerol metabolic process (GO:0006071) | 3.25096622 |
| 136 | cellular response to glucagon stimulus (GO:0071377) | 3.25083346 |
| 137 | regulation of peptide transport (GO:0090087) | 3.25011125 |
| 138 | exocrine pancreas development (GO:0031017) | 3.24207956 |
| 139 | positive regulation of cGMP metabolic process (GO:0030825) | 3.23758849 |
| 140 | homocysteine metabolic process (GO:0050667) | 3.22726786 |
| 141 | lipoprotein metabolic process (GO:0042157) | 3.22123181 |
| 142 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.19958402 |
| 143 | eosinophil migration (GO:0072677) | 3.19065434 |
| 144 | hormone secretion (GO:0046879) | 3.17614124 |
| 145 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.17411583 |
| 146 | oligosaccharide catabolic process (GO:0009313) | 3.17032386 |
| 147 | vitamin A metabolic process (GO:0006776) | 3.17002579 |
| 148 | cellular response to topologically incorrect protein (GO:0035967) | 3.16713397 |
| 149 | cellular response to unfolded protein (GO:0034620) | 3.16302553 |
| 150 | regulation of cardioblast proliferation (GO:0003264) | 3.16224176 |
| 151 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 3.16224176 |
| 152 | auditory receptor cell differentiation (GO:0042491) | 3.15217959 |
| 153 | sphingolipid catabolic process (GO:0030149) | 3.14828163 |
| 154 | ceramide catabolic process (GO:0046514) | 3.13760649 |
| 155 | renal filtration (GO:0097205) | 3.12433256 |
| 156 | positive regulation of growth hormone secretion (GO:0060124) | 3.11863723 |
| 157 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.11737448 |
| 158 | plasma lipoprotein particle assembly (GO:0034377) | 3.11629542 |
| 159 | macroautophagy (GO:0016236) | 3.08442719 |
| 160 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.06967159 |
| 161 | response to hepatocyte growth factor (GO:0035728) | 3.06967159 |
| 162 | ethanol oxidation (GO:0006069) | 3.06825716 |
| 163 | protein-lipid complex assembly (GO:0065005) | 3.06063210 |
| 164 | pancreas development (GO:0031016) | 3.05957619 |
| 165 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.04255987 |
| 166 | nitric oxide mediated signal transduction (GO:0007263) | 3.03822724 |
| 167 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 3.03495945 |
| 168 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.02650337 |
| 169 | hormone transport (GO:0009914) | 3.01132185 |
| 170 | peptide transport (GO:0015833) | 3.00420980 |
| 171 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.00393479 |
| 172 | L-phenylalanine catabolic process (GO:0006559) | 3.00393479 |
| 173 | GDP-mannose metabolic process (GO:0019673) | 2.98610918 |
| 174 | sulfate transmembrane transport (GO:1902358) | 2.98608391 |
| 175 | alkaloid metabolic process (GO:0009820) | 2.97844174 |
| 176 | iron coordination entity transport (GO:1901678) | 2.96212156 |
| 177 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.96168213 |
| 178 | membrane lipid catabolic process (GO:0046466) | 2.95935310 |
| 179 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.95781835 |
| 180 | fat-soluble vitamin metabolic process (GO:0006775) | 2.94544144 |
| 181 | peptide metabolic process (GO:0006518) | 2.93815925 |
| 182 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.93350664 |
| 183 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.93350664 |
| 184 | ER-nucleus signaling pathway (GO:0006984) | 2.92698647 |
| 185 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.91697505 |
| 186 | excretion (GO:0007588) | 2.91636909 |
| 187 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.91383727 |
| 188 | peptidyl-asparagine modification (GO:0018196) | 2.88725549 |
| 189 | signal transduction involved in regulation of gene expression (GO:0023019) | 2.87721421 |
| 190 | pharyngeal system development (GO:0060037) | 2.86729929 |
| 191 | Golgi organization (GO:0007030) | 2.83514816 |
| 192 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.82779852 |
| 193 | primitive streak formation (GO:0090009) | 2.82669916 |
| 194 | regulation of beta-amyloid formation (GO:1902003) | 2.77991343 |
| 195 | response to endoplasmic reticulum stress (GO:0034976) | 2.76854160 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 5.61007071 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.62924619 |
| 3 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.55317182 |
| 4 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 3.52008018 |
| 5 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.28892840 |
| 6 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 3.13170041 |
| 7 | GATA1_22025678_ChIP-Seq_K562_Human | 2.95700397 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.63559481 |
| 9 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.47329558 |
| 10 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.41750915 |
| 11 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.32178961 |
| 12 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.28932011 |
| 13 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.22092897 |
| 14 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.20408480 |
| 15 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.16435717 |
| 16 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 2.16045759 |
| 17 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 2.09506855 |
| 18 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 12.5526803 |
| 19 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.99362387 |
| 20 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.94801002 |
| 21 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.93518160 |
| 22 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.85344112 |
| 23 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.78853206 |
| 24 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.78576639 |
| 25 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.77764628 |
| 26 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.74662922 |
| 27 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.74317970 |
| 28 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.73476106 |
| 29 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.56918004 |
| 30 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.55836442 |
| 31 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.55396366 |
| 32 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54085451 |
| 33 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.53283060 |
| 34 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.51169020 |
| 35 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.50972157 |
| 36 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.47712261 |
| 37 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.45810255 |
| 38 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.44748476 |
| 39 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.44695596 |
| 40 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.43801304 |
| 41 | SA1_27219007_Chip-Seq_Bcells_Human | 1.43644476 |
| 42 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.42890219 |
| 43 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.42822292 |
| 44 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.42572029 |
| 45 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.41536747 |
| 46 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.40747611 |
| 47 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.40015621 |
| 48 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.37033654 |
| 49 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.36435374 |
| 50 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.34271148 |
| 51 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.33885582 |
| 52 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.33691664 |
| 53 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.33516953 |
| 54 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.33366027 |
| 55 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.33172620 |
| 56 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.31858092 |
| 57 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.27079771 |
| 58 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.26353980 |
| 59 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.26225205 |
| 60 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.24603094 |
| 61 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.24474323 |
| 62 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.23562775 |
| 63 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.21601349 |
| 64 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.21556318 |
| 65 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.21253544 |
| 66 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.21128319 |
| 67 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.19738128 |
| 68 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.19679613 |
| 69 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.19249980 |
| 70 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.18958268 |
| 71 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.18148387 |
| 72 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17838838 |
| 73 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.17809423 |
| 74 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.16878168 |
| 75 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.16397455 |
| 76 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.16382579 |
| 77 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.16306750 |
| 78 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.15601540 |
| 79 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14375940 |
| 80 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.14116905 |
| 81 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.14032482 |
| 82 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.13476807 |
| 83 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.13349984 |
| 84 | VDR_22108803_ChIP-Seq_LS180_Human | 1.13209343 |
| 85 | SOX2_21211035_ChIP-Seq_LN229_Human | 1.12193791 |
| 86 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.11399829 |
| 87 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11340808 |
| 88 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.11057263 |
| 89 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.10702860 |
| 90 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.10455279 |
| 91 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.08921765 |
| 92 | LDB1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.08431648 |
| 93 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.07418649 |
| 94 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.06349604 |
| 95 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.05420195 |
| 96 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.05416699 |
| 97 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.04493924 |
| 98 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.04229117 |
| 99 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 1.03356106 |
| 100 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.02951774 |
| 101 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.02839600 |
| 102 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.02658275 |
| 103 | P300_27268052_Chip-Seq_Bcells_Human | 1.02293316 |
| 104 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.02139016 |
| 105 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.01600765 |
| 106 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.01131367 |
| 107 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.00943325 |
| 108 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.99605184 |
| 109 | STAT3_23295773_ChIP-Seq_U87_Human | 0.98568694 |
| 110 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.97752034 |
| 111 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.96924335 |
| 112 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.96638234 |
| 113 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.95968508 |
| 114 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.95609251 |
| 115 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.95504540 |
| 116 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.95049232 |
| 117 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.94799250 |
| 118 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.94339397 |
| 119 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.93715680 |
| 120 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.93606593 |
| 121 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.93414899 |
| 122 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93211183 |
| 123 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.93112488 |
| 124 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.92833369 |
| 125 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.92581671 |
| 126 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.92093632 |
| 127 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.91112314 |
| 128 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.90374983 |
| 129 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.88167232 |
| 130 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.87092904 |
| 131 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.86534784 |
| 132 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.86337483 |
| 133 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85930950 |
| 134 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.85309425 |
| 135 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.82870997 |
| 136 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.82782997 |
| 137 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.82179004 |
| 138 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.81381340 |
| 139 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.80393454 |
| 140 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.80224427 |
| 141 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.79537617 |
| 142 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.79259470 |
| 143 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.76307561 |
| 144 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.76194087 |
| 145 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.75769112 |
| 146 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.75736158 |
| 147 | AR_20517297_ChIP-Seq_VCAP_Human | 0.74636244 |
| 148 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.74563227 |
| 149 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.74432437 |
| 150 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.73738925 |
| 151 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.72625361 |
| 152 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.72478843 |
| 153 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.72227619 |
| 154 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.71695089 |
| 155 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.71246719 |
| 156 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.71246719 |
| 157 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.70750785 |
| 158 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.70383471 |
| 159 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.69598402 |
| 160 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.69534855 |
| 161 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.69425415 |
| 162 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.68277977 |
| 163 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.67584458 |
| 164 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.67518144 |
| 165 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.67473003 |
| 166 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.67089577 |
| 167 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.66914012 |
| 168 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.66233553 |
| 169 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.65747847 |
| 170 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.65573758 |
| 171 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.65499507 |
| 172 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.64780399 |
| 173 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.64283115 |
| 174 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.63771649 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003183_abnormal_peptide_metabolism | 7.06279735 |
| 2 | MP0005360_urolithiasis | 6.49915906 |
| 3 | MP0009379_abnormal_foot_pigmentation | 4.82623399 |
| 4 | MP0003195_calcinosis | 4.78674616 |
| 5 | * MP0000013_abnormal_adipose_tissue | 4.07082842 |
| 6 | MP0005379_endocrine/exocrine_gland_phen | 3.98194300 |
| 7 | MP0002909_abnormal_adrenal_gland | 3.89034981 |
| 8 | MP0010386_abnormal_urinary_bladder | 3.85063033 |
| 9 | MP0002877_abnormal_melanocyte_morpholog | 3.62493483 |
| 10 | MP0005085_abnormal_gallbladder_physiolo | 3.51383716 |
| 11 | MP0001944_abnormal_pancreas_morphology | 3.48158718 |
| 12 | MP0002693_abnormal_pancreas_physiology | 3.20374318 |
| 13 | MP0002837_dystrophic_cardiac_calcinosis | 3.09211164 |
| 14 | MP0004043_abnormal_pH_regulation | 3.08108466 |
| 15 | MP0005220_abnormal_exocrine_pancreas | 3.00761480 |
| 16 | MP0009840_abnormal_foam_cell | 2.95751296 |
| 17 | MP0010155_abnormal_intestine_physiology | 2.73411609 |
| 18 | MP0003122_maternal_imprinting | 2.72309370 |
| 19 | MP0000678_abnormal_parathyroid_gland | 2.70643722 |
| 20 | MP0004147_increased_porphyrin_level | 2.64974789 |
| 21 | MP0005084_abnormal_gallbladder_morpholo | 2.38675721 |
| 22 | MP0005409_darkened_coat_color | 2.34480695 |
| 23 | * MP0000003_abnormal_adipose_tissue | 2.31821125 |
| 24 | MP0003283_abnormal_digestive_organ | 2.25222718 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 2.24379123 |
| 26 | MP0002138_abnormal_hepatobiliary_system | 2.20886486 |
| 27 | MP0004264_abnormal_extraembryonic_tissu | 2.12217655 |
| 28 | MP0001986_abnormal_taste_sensitivity | 2.09448741 |
| 29 | MP0003172_abnormal_lysosome_physiology | 2.08696597 |
| 30 | MP0000490_abnormal_crypts_of | 2.05684605 |
| 31 | MP0010352_gastrointestinal_tract_polyps | 2.03162924 |
| 32 | * MP0002078_abnormal_glucose_homeostasis | 2.01483452 |
| 33 | MP0010329_abnormal_lipoprotein_level | 2.00550051 |
| 34 | MP0002163_abnormal_gland_morphology | 1.98652886 |
| 35 | MP0006072_abnormal_retinal_apoptosis | 1.96069499 |
| 36 | MP0002638_abnormal_pupillary_reflex | 1.90152379 |
| 37 | MP0008961_abnormal_basal_metabolism | 1.89857939 |
| 38 | MP0001188_hyperpigmentation | 1.86798572 |
| 39 | MP0001756_abnormal_urination | 1.86520421 |
| 40 | MP0004858_abnormal_nervous_system | 1.84760865 |
| 41 | MP0001873_stomach_inflammation | 1.83515833 |
| 42 | MP0001765_abnormal_ion_homeostasis | 1.82382043 |
| 43 | MP0006292_abnormal_olfactory_placode | 1.79472900 |
| 44 | MP0004270_analgesia | 1.78201041 |
| 45 | MP0000477_abnormal_intestine_morphology | 1.73449283 |
| 46 | MP0005365_abnormal_bile_salt | 1.70272536 |
| 47 | MP0002938_white_spotting | 1.56984137 |
| 48 | MP0005257_abnormal_intraocular_pressure | 1.51885664 |
| 49 | MP0001663_abnormal_digestive_system | 1.51591153 |
| 50 | MP0005166_decreased_susceptibility_to | 1.50317045 |
| 51 | MP0002928_abnormal_bile_duct | 1.45409818 |
| 52 | MP0005670_abnormal_white_adipose | 1.35377705 |
| 53 | MP0002234_abnormal_pharynx_morphology | 1.34507161 |
| 54 | MP0000613_abnormal_salivary_gland | 1.34137118 |
| 55 | MP0005381_digestive/alimentary_phenotyp | 1.29237457 |
| 56 | MP0003806_abnormal_nucleotide_metabolis | 1.29126714 |
| 57 | MP0003300_gastrointestinal_ulcer | 1.28747982 |
| 58 | MP0003787_abnormal_imprinting | 1.28704036 |
| 59 | MP0002136_abnormal_kidney_physiology | 1.28522220 |
| 60 | MP0005058_abnormal_lysosome_morphology | 1.28398361 |
| 61 | MP0005636_abnormal_mineral_homeostasis | 1.27061941 |
| 62 | MP0004782_abnormal_surfactant_physiolog | 1.22908599 |
| 63 | MP0002796_impaired_skin_barrier | 1.20317581 |
| 64 | MP0009643_abnormal_urine_homeostasis | 1.20142449 |
| 65 | * MP0003953_abnormal_hormone_level | 1.19645053 |
| 66 | MP0002896_abnormal_bone_mineralization | 1.16547719 |
| 67 | * MP0005645_abnormal_hypothalamus_physiol | 1.15720085 |
| 68 | MP0003121_genomic_imprinting | 1.14150535 |
| 69 | MP0003718_maternal_effect | 1.14079849 |
| 70 | MP0005408_hypopigmentation | 1.13008550 |
| 71 | MP0001502_abnormal_circadian_rhythm | 1.12500886 |
| 72 | MP0000631_abnormal_neuroendocrine_gland | 1.12424550 |
| 73 | MP0003252_abnormal_bile_duct | 1.10145319 |
| 74 | MP0001501_abnormal_sleep_pattern | 1.09166648 |
| 75 | MP0003123_paternal_imprinting | 1.07138171 |
| 76 | MP0000015_abnormal_ear_pigmentation | 1.06885646 |
| 77 | MP0005174_abnormal_tail_pigmentation | 1.06708386 |
| 78 | MP0002822_catalepsy | 1.06603753 |
| 79 | MP0004019_abnormal_vitamin_homeostasis | 1.05072540 |
| 80 | MP0000538_abnormal_urinary_bladder | 1.04449777 |
| 81 | MP0002118_abnormal_lipid_homeostasis | 1.04179509 |
| 82 | * MP0003959_abnormal_lean_body | 1.03107037 |
| 83 | MP0002751_abnormal_autonomic_nervous | 1.02908504 |
| 84 | MP0000639_abnormal_adrenal_gland | 1.02570178 |
| 85 | MP0001764_abnormal_homeostasis | 1.00577630 |
| 86 | MP0002098_abnormal_vibrissa_morphology | 0.99390822 |
| 87 | * MP0005375_adipose_tissue_phenotype | 0.99171242 |
| 88 | MP0002734_abnormal_mechanical_nocicepti | 0.97382666 |
| 89 | MP0000230_abnormal_systemic_arterial | 0.96244255 |
| 90 | MP0003868_abnormal_feces_composition | 0.94345709 |
| 91 | MP0003879_abnormal_hair_cell | 0.90949831 |
| 92 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.89357456 |
| 93 | MP0010234_abnormal_vibrissa_follicle | 0.88070822 |
| 94 | MP0001845_abnormal_inflammatory_respons | 0.86749988 |
| 95 | MP0005319_abnormal_enzyme/_coenzyme | 0.85886221 |
| 96 | MP0003119_abnormal_digestive_system | 0.85868768 |
| 97 | MP0002971_abnormal_brown_adipose | 0.84200570 |
| 98 | MP0003693_abnormal_embryo_hatching | 0.84134159 |
| 99 | MP0004145_abnormal_muscle_electrophysio | 0.82120090 |
| 100 | MP0003045_fibrosis | 0.81825899 |
| 101 | MP0009333_abnormal_splenocyte_physiolog | 0.81803044 |
| 102 | MP0003890_abnormal_embryonic-extraembry | 0.81353008 |
| 103 | MP0001664_abnormal_digestion | 0.79947258 |
| 104 | MP0005666_abnormal_adipose_tissue | 0.79357999 |
| 105 | MP0002277_abnormal_respiratory_mucosa | 0.78859204 |
| 106 | MP0008872_abnormal_physiological_respon | 0.78053271 |
| 107 | MP0001666_abnormal_nutrient_absorption | 0.77055367 |
| 108 | MP0005646_abnormal_pituitary_gland | 0.77034523 |
| 109 | MP0000681_abnormal_thyroid_gland | 0.76962258 |
| 110 | MP0002733_abnormal_thermal_nociception | 0.76228705 |
| 111 | MP0001881_abnormal_mammary_gland | 0.74982809 |
| 112 | MP0009785_altered_susceptibility_to | 0.74929226 |
| 113 | MP0001270_distended_abdomen | 0.73815734 |
| 114 | MP0005535_abnormal_body_temperature | 0.72680424 |
| 115 | MP0003724_increased_susceptibility_to | 0.72280309 |
| 116 | MP0005448_abnormal_energy_balance | 0.71811267 |
| 117 | MP0001299_abnormal_eye_distance/ | 0.71285096 |
| 118 | MP0000609_abnormal_liver_physiology | 0.70199229 |
| 119 | MP0006054_spinal_hemorrhage | 0.66564721 |
| 120 | MP0002184_abnormal_innervation | 0.66275598 |
| 121 | MP0005332_abnormal_amino_acid | 0.66093834 |
| 122 | MP0005451_abnormal_body_composition | 0.64986485 |
| 123 | MP0002254_reproductive_system_inflammat | 0.64837526 |
| 124 | MP0008469_abnormal_protein_level | 0.63849185 |
| 125 | MP0000537_abnormal_urethra_morphology | 0.62505361 |
| 126 | MP0000427_abnormal_hair_cycle | 0.62444401 |
| 127 | MP0002168_other_aberrant_phenotype | 0.61521346 |
| 128 | MP0009115_abnormal_fat_cell | 0.61454464 |
| 129 | MP0006082_CNS_inflammation | 0.60376675 |
| 130 | MP0010678_abnormal_skin_adnexa | 0.60357396 |
| 131 | MP0002876_abnormal_thyroid_physiology | 0.59834887 |
| 132 | MP0002557_abnormal_social/conspecific_i | 0.59419314 |
| 133 | MP0005253_abnormal_eye_physiology | 0.58937049 |
| 134 | MP0002177_abnormal_outer_ear | 0.58691702 |
| 135 | MP0005025_abnormal_response_to | 0.58631239 |
| 136 | * MP0005452_abnormal_adipose_tissue | 0.58565460 |
| 137 | MP0005387_immune_system_phenotype | 0.58453173 |
| 138 | MP0001790_abnormal_immune_system | 0.58453173 |
| 139 | MP0000462_abnormal_digestive_system | 0.58371826 |
| 140 | MP0004233_abnormal_muscle_weight | 0.57007401 |
| 141 | MP0000465_gastrointestinal_hemorrhage | 0.56841654 |
| 142 | MP0003633_abnormal_nervous_system | 0.56272192 |
| 143 | * MP0002069_abnormal_eating/drinking_beha | 0.55871356 |
| 144 | MP0002090_abnormal_vision | 0.54278021 |
| 145 | MP0001970_abnormal_pain_threshold | 0.52011667 |
| 146 | MP0003866_abnormal_defecation | 0.51552424 |
| 147 | MP0001186_pigmentation_phenotype | 0.50133398 |
| 148 | MP0002272_abnormal_nervous_system | 0.48449388 |
| 149 | MP0004947_skin_inflammation | 0.47249707 |
| 150 | MP0008004_abnormal_stomach_pH | 0.46402698 |
| 151 | MP0009703_decreased_birth_body | 0.46264036 |
| 152 | MP0002139_abnormal_hepatobiliary_system | 0.46234077 |
| 153 | * MP0009642_abnormal_blood_homeostasis | 0.45632175 |
| 154 | MP0002127_abnormal_cardiovascular_syste | 0.45352912 |
| 155 | MP0000470_abnormal_stomach_morphology | 0.44987037 |
| 156 | MP0005501_abnormal_skin_physiology | 0.44977827 |
| 157 | MP0000955_abnormal_spinal_cord | 0.43727328 |
| 158 | MP0009672_abnormal_birth_weight | 0.43605933 |
| 159 | MP0001485_abnormal_pinna_reflex | 0.43452544 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 8.35367784 |
| 2 | Hyperinsulinemic hypoglycemia (HP:0000825) | 7.62956221 |
| 3 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 7.42651391 |
| 4 | Hypoglycemic seizures (HP:0002173) | 6.96695429 |
| 5 | Malnutrition (HP:0004395) | 6.90226214 |
| 6 | Hyperglycemia (HP:0003074) | 6.38444727 |
| 7 | Retinal atrophy (HP:0001105) | 6.22655412 |
| 8 | Symptomatic seizures (HP:0011145) | 6.19666637 |
| 9 | Hypoglycemic coma (HP:0001325) | 6.14063442 |
| 10 | Pancreatic islet-cell hyperplasia (HP:0004510) | 5.62903178 |
| 11 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 5.59957883 |
| 12 | Hydroxyprolinuria (HP:0003080) | 5.52008409 |
| 13 | Abnormality of proline metabolism (HP:0010907) | 5.52008409 |
| 14 | Abnormality of the pancreatic islet cells (HP:0006476) | 5.48316711 |
| 15 | Abnormality of endocrine pancreas physiology (HP:0012093) | 5.48316711 |
| 16 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 5.10493492 |
| 17 | Ketoacidosis (HP:0001993) | 5.00620610 |
| 18 | Late onset (HP:0003584) | 4.97223686 |
| 19 | Large for gestational age (HP:0001520) | 4.59763178 |
| 20 | Insulin-resistant diabetes mellitus (HP:0000831) | 4.32686079 |
| 21 | Ileus (HP:0002595) | 4.30367307 |
| 22 | Increased purine levels (HP:0004368) | 4.27592014 |
| 23 | Hyperuricemia (HP:0002149) | 4.27592014 |
| 24 | Confusion (HP:0001289) | 4.06674222 |
| 25 | Chronic diarrhea (HP:0002028) | 4.04146442 |
| 26 | Systemic lupus erythematosus (HP:0002725) | 3.92826153 |
| 27 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.91487918 |
| 28 | Abnormality of urine glucose concentration (HP:0011016) | 3.90123076 |
| 29 | Glycosuria (HP:0003076) | 3.90123076 |
| 30 | Agitation (HP:0000713) | 3.83099806 |
| 31 | Fat malabsorption (HP:0002630) | 3.82698039 |
| 32 | Dysostosis multiplex (HP:0000943) | 3.81346902 |
| 33 | Metabolic alkalosis (HP:0200114) | 3.55671060 |
| 34 | Abnormality of magnesium homeostasis (HP:0004921) | 3.54630849 |
| 35 | Hyperparathyroidism (HP:0000843) | 3.49818231 |
| 36 | Prominent metopic ridge (HP:0005487) | 3.45368314 |
| 37 | Hypobetalipoproteinemia (HP:0003563) | 3.37917842 |
| 38 | Decreased circulating renin level (HP:0003351) | 3.35077980 |
| 39 | Alkalosis (HP:0001948) | 3.28191696 |
| 40 | Hyperglycinuria (HP:0003108) | 3.26279357 |
| 41 | Abnormality of purine metabolism (HP:0004352) | 3.20983029 |
| 42 | Nausea (HP:0002018) | 3.13631214 |
| 43 | Widely patent fontanelles and sutures (HP:0004492) | 3.02337129 |
| 44 | Dysautonomia (HP:0002459) | 3.00025970 |
| 45 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.99649454 |
| 46 | Renal tubular acidosis (HP:0001947) | 2.92608363 |
| 47 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.92283713 |
| 48 | Abnormality of glycine metabolism (HP:0010895) | 2.92283713 |
| 49 | Focal segmental glomerulosclerosis (HP:0000097) | 2.92229957 |
| 50 | Abnormality of the metopic suture (HP:0005556) | 2.91649867 |
| 51 | Mucopolysacchariduria (HP:0008155) | 2.91285081 |
| 52 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.91285081 |
| 53 | Neuroendocrine neoplasm (HP:0100634) | 2.90196301 |
| 54 | Hypokalemia (HP:0002900) | 2.89554450 |
| 55 | Menstrual irregularities (HP:0000858) | 2.87252112 |
| 56 | Insulin resistance (HP:0000855) | 2.86853890 |
| 57 | Abnormality of nucleobase metabolism (HP:0010932) | 2.85589314 |
| 58 | Ketosis (HP:0001946) | 2.81788427 |
| 59 | Nephrolithiasis (HP:0000787) | 2.81708484 |
| 60 | Osteomalacia (HP:0002749) | 2.77652705 |
| 61 | Broad face (HP:0000283) | 2.76877606 |
| 62 | Papilledema (HP:0001085) | 2.73624355 |
| 63 | EEG with generalized epileptiform discharges (HP:0011198) | 2.73339596 |
| 64 | Tetany (HP:0001281) | 2.70559403 |
| 65 | Hypsarrhythmia (HP:0002521) | 2.70153397 |
| 66 | Steatorrhea (HP:0002570) | 2.68272085 |
| 67 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.65886465 |
| 68 | Villous atrophy (HP:0011473) | 2.65886465 |
| 69 | Hyperkalemia (HP:0002153) | 2.65508086 |
| 70 | Hyperphosphatemia (HP:0002905) | 2.64549930 |
| 71 | Abnormal pancreas size (HP:0012094) | 2.62792010 |
| 72 | Right ventricular cardiomyopathy (HP:0011663) | 2.62659640 |
| 73 | Dicarboxylic aciduria (HP:0003215) | 2.62645816 |
| 74 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.62645816 |
| 75 | Congenital sensorineural hearing impairment (HP:0008527) | 2.61451153 |
| 76 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.60946972 |
| 77 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.60946972 |
| 78 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.60946972 |
| 79 | Epileptiform EEG discharges (HP:0011182) | 2.60838931 |
| 80 | Macroorchidism (HP:0000053) | 2.60491941 |
| 81 | Orthostatic hypotension (HP:0001278) | 2.60246130 |
| 82 | Pheochromocytoma (HP:0002666) | 2.57737167 |
| 83 | Megaloblastic anemia (HP:0001889) | 2.57730449 |
| 84 | Xanthomatosis (HP:0000991) | 2.53136234 |
| 85 | Abnormality of potassium homeostasis (HP:0011042) | 2.51518488 |
| 86 | Potter facies (HP:0002009) | 2.51444843 |
| 87 | Facial shape deformation (HP:0011334) | 2.51444843 |
| 88 | Abnormality of renin-angiotensin system (HP:0000847) | 2.50032371 |
| 89 | Flattened epiphyses (HP:0003071) | 2.48726150 |
| 90 | Progressive neurologic deterioration (HP:0002344) | 2.46949961 |
| 91 | Methylmalonic aciduria (HP:0012120) | 2.42208323 |
| 92 | Pili torti (HP:0003777) | 2.41111737 |
| 93 | Vacuolated lymphocytes (HP:0001922) | 2.39695992 |
| 94 | Pigmentary retinal degeneration (HP:0001146) | 2.39423473 |
| 95 | Protuberant abdomen (HP:0001538) | 2.38538050 |
| 96 | Renal tubular dysfunction (HP:0000124) | 2.36463092 |
| 97 | Wide cranial sutures (HP:0010537) | 2.34370804 |
| 98 | Hyperammonemia (HP:0001987) | 2.32718771 |
| 99 | Hypotension (HP:0002615) | 2.32674248 |
| 100 | Unilateral renal agenesis (HP:0000122) | 2.32654232 |
| 101 | Glomerulosclerosis (HP:0000096) | 2.30514091 |
| 102 | Abnormality of the intrinsic pathway (HP:0010989) | 2.30151377 |
| 103 | Acanthocytosis (HP:0001927) | 2.30129526 |
| 104 | Hypomagnesemia (HP:0002917) | 2.29992681 |
| 105 | Congenital glaucoma (HP:0001087) | 2.29802301 |
| 106 | Petechiae (HP:0000967) | 2.28056029 |
| 107 | Vascular calcification (HP:0004934) | 2.27401497 |
| 108 | Glomerulonephritis (HP:0000099) | 2.26105979 |
| 109 | Increased CSF protein (HP:0002922) | 2.24743537 |
| 110 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.23900607 |
| 111 | Hypoplasia of the fovea (HP:0007750) | 2.23900607 |
| 112 | Restlessness (HP:0000711) | 2.22518024 |
| 113 | Growth hormone excess (HP:0000845) | 2.21811257 |
| 114 | Enlarged kidneys (HP:0000105) | 2.19729340 |
| 115 | Increased circulating renin level (HP:0000848) | 2.18104329 |
| 116 | Posterior subcapsular cataract (HP:0007787) | 2.17849122 |
| 117 | Abnormal tarsal ossification (HP:0008369) | 2.17358518 |
| 118 | Flat acetabular roof (HP:0003180) | 2.12179705 |
| 119 | Abnormality of chloride homeostasis (HP:0011422) | 2.10888915 |
| 120 | Hypophosphatemia (HP:0002148) | 2.09372708 |
| 121 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.08366662 |
| 122 | Abnormality of the fovea (HP:0000493) | 2.07270341 |
| 123 | Intestinal atresia (HP:0011100) | 2.06518734 |
| 124 | Intrahepatic cholestasis (HP:0001406) | 2.05257099 |
| 125 | Hyperphosphaturia (HP:0003109) | 2.03956615 |
| 126 | Eczematoid dermatitis (HP:0000976) | 2.03645834 |
| 127 | Generalized hyperpigmentation (HP:0007440) | 2.02620185 |
| 128 | Lethargy (HP:0001254) | 2.02540265 |
| 129 | Hypercortisolism (HP:0001578) | 2.00809033 |
| 130 | Hypoalbuminemia (HP:0003073) | 2.00493485 |
| 131 | Abnormal albumin level (HP:0012116) | 2.00493485 |
| 132 | Gastrointestinal dysmotility (HP:0002579) | 2.00253165 |
| 133 | Hyperactive renin-angiotensin system (HP:0000841) | 2.00206087 |
| 134 | Metabolic acidosis (HP:0001942) | 2.00049734 |
| 135 | Limb hypertonia (HP:0002509) | 1.98874297 |
| 136 | Abnormal biliary tract morphology (HP:0012440) | 1.97669467 |
| 137 | Abdominal distention (HP:0003270) | 1.96124743 |
| 138 | Enlarged epiphyses (HP:0010580) | 1.95917340 |
| 139 | Hemorrhage of the eye (HP:0011885) | 1.95390889 |
| 140 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.93695570 |
| 141 | Atelectasis (HP:0100750) | 1.93184858 |
| 142 | Cardiovascular calcification (HP:0011915) | 1.92124803 |
| 143 | Adrenal overactivity (HP:0002717) | 1.89558955 |
| 144 | Pancreatitis (HP:0001733) | 1.89523721 |
| 145 | Hepatoblastoma (HP:0002884) | 1.88436027 |
| 146 | Axonal loss (HP:0003447) | 1.82705152 |
| 147 | Tachypnea (HP:0002789) | 1.82492674 |
| 148 | Chronic bronchitis (HP:0004469) | 1.82291815 |
| 149 | Nephritis (HP:0000123) | 1.82291793 |
| 150 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.82057354 |
| 151 | Gout (HP:0001997) | 1.81204197 |
| 152 | Abnormal hair laboratory examination (HP:0003328) | 1.80934087 |
| 153 | Conjugated hyperbilirubinemia (HP:0002908) | 1.80663431 |
| 154 | Skin nodule (HP:0200036) | 1.79115753 |
| 155 | Hypothermia (HP:0002045) | 1.78888002 |
| 156 | Hyperaldosteronism (HP:0000859) | 1.78308878 |
| 157 | Abnormality of renal excretion (HP:0011036) | 1.78196964 |
| 158 | Proximal tubulopathy (HP:0000114) | 1.77998479 |
| 159 | Hypolipoproteinemia (HP:0010981) | 1.77405685 |
| 160 | Thin bony cortex (HP:0002753) | 1.74262196 |
| 161 | Ventricular fibrillation (HP:0001663) | 1.74049791 |
| 162 | Cortical visual impairment (HP:0100704) | 1.72605232 |
| 163 | Blue irides (HP:0000635) | 1.71947649 |
| 164 | Flared iliac wings (HP:0002869) | 1.70617915 |
| 165 | Neoplasm of the heart (HP:0100544) | 1.69192110 |
| 166 | Hemiparesis (HP:0001269) | 1.69087499 |
| 167 | Abnormality of vitamin metabolism (HP:0100508) | 1.68938900 |
| 168 | Testicular neoplasm (HP:0010788) | 1.65870626 |
| 169 | Bifid tongue (HP:0010297) | 1.62881329 |
| 170 | Spondylolisthesis (HP:0003302) | 1.62565561 |
| 171 | Abnormality of glycolipid metabolism (HP:0010969) | 1.61576015 |
| 172 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.61576015 |
| 173 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.61576015 |
| 174 | Abnormal urine phosphate concentration (HP:0012599) | 1.59205688 |
| 175 | Long toe (HP:0010511) | 1.56713407 |
| 176 | Abnormality of vitamin B metabolism (HP:0004340) | 1.56628848 |
| 177 | Generalized aminoaciduria (HP:0002909) | 1.56353006 |
| 178 | Lipid accumulation in hepatocytes (HP:0006561) | 1.53801344 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK3 | 8.55018222 |
| 2 | ACVR1B | 7.64647977 |
| 3 | MAPK15 | 6.02670266 |
| 4 | PIK3CG | 5.56267705 |
| 5 | STK39 | 4.35101296 |
| 6 | INSRR | 4.22884569 |
| 7 | MST1R | 3.73484702 |
| 8 | TAOK3 | 3.54394203 |
| 9 | FRK | 3.44246128 |
| 10 | WNK4 | 3.26020925 |
| 11 | MAP3K2 | 2.70549152 |
| 12 | MST4 | 2.55460028 |
| 13 | UHMK1 | 2.49647244 |
| 14 | OXSR1 | 2.37114773 |
| 15 | PASK | 2.20063978 |
| 16 | MAP3K12 | 2.17478216 |
| 17 | HIPK2 | 2.16977943 |
| 18 | EPHB2 | 2.01607637 |
| 19 | MAP3K10 | 2.00136203 |
| 20 | PRKD3 | 1.82028351 |
| 21 | MYLK | 1.58809757 |
| 22 | MAP2K6 | 1.57432971 |
| 23 | ERN1 | 1.54802347 |
| 24 | STK24 | 1.51984809 |
| 25 | MAP3K1 | 1.44033246 |
| 26 | EPHA3 | 1.36307845 |
| 27 | CDK19 | 1.30230907 |
| 28 | KSR2 | 1.28607436 |
| 29 | WNK1 | 1.26149952 |
| 30 | DYRK1B | 1.25957549 |
| 31 | PIK3CA | 1.25177633 |
| 32 | TLK1 | 1.24965043 |
| 33 | TYK2 | 1.24135347 |
| 34 | GRK1 | 1.23634794 |
| 35 | MAP4K1 | 1.23471914 |
| 36 | IRAK3 | 1.22626795 |
| 37 | AKT3 | 1.16454357 |
| 38 | EPHA2 | 1.14258105 |
| 39 | IRAK1 | 1.13146377 |
| 40 | PAK3 | 1.12885628 |
| 41 | ABL2 | 1.10624415 |
| 42 | MATK | 1.07763451 |
| 43 | LMTK2 | 1.07062371 |
| 44 | TESK2 | 1.04844412 |
| 45 | CDC42BPA | 1.02670609 |
| 46 | ARAF | 1.02046949 |
| 47 | PDK2 | 1.00126287 |
| 48 | IKBKE | 0.99980474 |
| 49 | CAMKK2 | 0.94789788 |
| 50 | ERBB2 | 0.92302415 |
| 51 | NTRK3 | 0.87127493 |
| 52 | BRAF | 0.86950640 |
| 53 | PTK6 | 0.83789631 |
| 54 | PTK2 | 0.82766039 |
| 55 | CASK | 0.82507860 |
| 56 | BMPR1B | 0.81906313 |
| 57 | SCYL2 | 0.80424004 |
| 58 | DMPK | 0.79528561 |
| 59 | ZAP70 | 0.77072797 |
| 60 | NTRK1 | 0.75644552 |
| 61 | FER | 0.75253979 |
| 62 | PDPK1 | 0.74311294 |
| 63 | MAP3K13 | 0.74275423 |
| 64 | FLT3 | 0.73549323 |
| 65 | MAP3K11 | 0.73288505 |
| 66 | IRAK4 | 0.72042830 |
| 67 | FGFR3 | 0.68964345 |
| 68 | MAPK11 | 0.65587266 |
| 69 | GRK6 | 0.64210778 |
| 70 | DDR2 | 0.62295060 |
| 71 | PRKCH | 0.61514533 |
| 72 | MAP2K2 | 0.60922952 |
| 73 | PRKD2 | 0.57981584 |
| 74 | RIPK1 | 0.57549420 |
| 75 | PRKCI | 0.55275704 |
| 76 | TBK1 | 0.54566954 |
| 77 | PRKCA | 0.54194150 |
| 78 | STK16 | 0.54174165 |
| 79 | BMX | 0.52928853 |
| 80 | PIM1 | 0.52101919 |
| 81 | BRSK2 | 0.51168030 |
| 82 | PRKACG | 0.49550358 |
| 83 | MAP3K9 | 0.48638827 |
| 84 | BRD4 | 0.48069750 |
| 85 | PAK4 | 0.45139849 |
| 86 | CAMK2D | 0.44732664 |
| 87 | BMPR2 | 0.43920638 |
| 88 | MELK | 0.43364581 |
| 89 | DAPK2 | 0.43019552 |
| 90 | IGF1R | 0.41980824 |
| 91 | PRKCZ | 0.41852269 |
| 92 | EIF2AK3 | 0.41775352 |
| 93 | CSF1R | 0.41483884 |
| 94 | PDK1 | 0.40886522 |
| 95 | MAP2K1 | 0.40444996 |
| 96 | MAP3K8 | 0.40425203 |
| 97 | ERBB4 | 0.40174354 |
| 98 | RPS6KL1 | 0.39859145 |
| 99 | RPS6KC1 | 0.39859145 |
| 100 | NLK | 0.39323346 |
| 101 | SGK494 | 0.36379186 |
| 102 | SGK223 | 0.36379186 |
| 103 | ADRBK2 | 0.36344643 |
| 104 | SRC | 0.35980535 |
| 105 | PRKAA2 | 0.35614914 |
| 106 | RPS6KA5 | 0.35486061 |
| 107 | RPS6KA6 | 0.34584862 |
| 108 | PDGFRA | 0.34377259 |
| 109 | NEK6 | 0.34351252 |
| 110 | STK3 | 0.34221515 |
| 111 | FGFR4 | 0.33131975 |
| 112 | STK38L | 0.33021170 |
| 113 | EPHA4 | 0.32875717 |
| 114 | EPHB1 | 0.32481822 |
| 115 | PRKG2 | 0.31976893 |
| 116 | LRRK2 | 0.31929026 |
| 117 | MTOR | 0.31850260 |
| 118 | RPS6KA2 | 0.31694937 |
| 119 | PRKCQ | 0.31403180 |
| 120 | NME1 | 0.31212456 |
| 121 | RET | 0.30674769 |
| 122 | CAMK1G | 0.29278331 |
| 123 | YES1 | 0.29248009 |
| 124 | ITK | 0.28437060 |
| 125 | STK4 | 0.28166537 |
| 126 | SGK2 | 0.27085523 |
| 127 | DYRK1A | 0.27084811 |
| 128 | GSK3A | 0.27015086 |
| 129 | PRKCE | 0.26747409 |
| 130 | SMG1 | 0.26247757 |
| 131 | TAOK1 | 0.24975004 |
| 132 | AKT2 | 0.24938995 |
| 133 | MAP4K2 | 0.24707607 |
| 134 | TESK1 | 0.23982228 |
| 135 | RPS6KB1 | 0.23677523 |
| 136 | KSR1 | 0.23610953 |
| 137 | PRKAA1 | 0.23184426 |
| 138 | BRSK1 | 0.22630849 |
| 139 | JAK2 | 0.21984043 |
| 140 | CSNK1A1 | 0.21292836 |
| 141 | MET | 0.21073618 |
| 142 | PNCK | 0.20131147 |
| 143 | IRAK2 | 0.20075308 |
| 144 | DYRK3 | 0.19706078 |
| 145 | CHUK | 0.19509909 |
| 146 | ERBB3 | 0.18795473 |
| 147 | SGK1 | 0.16625258 |
| 148 | PRKDC | 0.16484506 |
| 149 | MARK2 | 0.16067925 |
| 150 | DAPK1 | 0.15948349 |
| 151 | SGK3 | 0.15938888 |
| 152 | ZAK | 0.14271723 |
| 153 | MAPKAPK3 | 0.14103685 |
| 154 | RPS6KA3 | 0.13553542 |
| 155 | PRKACA | 0.12985633 |
| 156 | TRIB3 | 0.12764643 |
| 157 | CAMK2B | 0.12449202 |
| 158 | RPS6KA1 | 0.12005116 |
| 159 | CSK | 0.11983525 |
| 160 | PRKD1 | 0.11762341 |
| 161 | MAPKAPK2 | 0.11637557 |
| 162 | MAPK10 | 0.10815867 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 9.60189322 |
| 2 | Protein export_Homo sapiens_hsa03060 | 5.35871976 |
| 3 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 4.93100909 |
| 4 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.99966039 |
| 5 | Insulin secretion_Homo sapiens_hsa04911 | 3.57116492 |
| 6 | Mineral absorption_Homo sapiens_hsa04978 | 2.94027668 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.89559476 |
| 8 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.79221326 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.64862705 |
| 10 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.20913594 |
| 11 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.19970262 |
| 12 | Histidine metabolism_Homo sapiens_hsa00340 | 2.17910171 |
| 13 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.15915438 |
| 14 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.12255594 |
| 15 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.11933228 |
| 16 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.06416757 |
| 17 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.02800561 |
| 18 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.92672322 |
| 19 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.80723735 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.77352627 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.75285064 |
| 22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.71914938 |
| 23 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.70113112 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.69122576 |
| 25 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.69085563 |
| 26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.67887627 |
| 27 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.63782103 |
| 28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.60321240 |
| 29 | Circadian rhythm_Homo sapiens_hsa04710 | 1.57141695 |
| 30 | Lysosome_Homo sapiens_hsa04142 | 1.51471921 |
| 31 | Cocaine addiction_Homo sapiens_hsa05030 | 1.50848479 |
| 32 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.47147483 |
| 33 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.43145696 |
| 34 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.40792377 |
| 35 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.36590965 |
| 36 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.34154008 |
| 37 | Asthma_Homo sapiens_hsa05310 | 1.33269823 |
| 38 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.29418602 |
| 39 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.24884721 |
| 40 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.24494320 |
| 41 | Prion diseases_Homo sapiens_hsa05020 | 1.23834194 |
| 42 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.21667518 |
| 43 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.20004013 |
| 44 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.19802651 |
| 45 | Bile secretion_Homo sapiens_hsa04976 | 1.19205929 |
| 46 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.17802736 |
| 47 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.16176883 |
| 48 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.13601200 |
| 49 | Sulfur relay system_Homo sapiens_hsa04122 | 1.11107985 |
| 50 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.09347078 |
| 51 | Allograft rejection_Homo sapiens_hsa05330 | 1.07498726 |
| 52 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.06658068 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 1.04851911 |
| 54 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.04577503 |
| 55 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.01305079 |
| 56 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.97525942 |
| 57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96783874 |
| 58 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.96516649 |
| 59 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.95832657 |
| 60 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.95755582 |
| 61 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.94773051 |
| 62 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.87479694 |
| 63 | GABAergic synapse_Homo sapiens_hsa04727 | 0.85819571 |
| 64 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.83585520 |
| 65 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.83003928 |
| 66 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.82619648 |
| 67 | Circadian entrainment_Homo sapiens_hsa04713 | 0.82047297 |
| 68 | Taste transduction_Homo sapiens_hsa04742 | 0.80743116 |
| 69 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.79945433 |
| 70 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.75553122 |
| 71 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.71097104 |
| 72 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.70630867 |
| 73 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.70182521 |
| 74 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.63964206 |
| 75 | Tight junction_Homo sapiens_hsa04530 | 0.63532327 |
| 76 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.61738501 |
| 77 | Renin secretion_Homo sapiens_hsa04924 | 0.61207813 |
| 78 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.60267507 |
| 79 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.59942211 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.59154261 |
| 81 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.58098993 |
| 82 | Long-term potentiation_Homo sapiens_hsa04720 | 0.57420956 |
| 83 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.56092825 |
| 84 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.54436667 |
| 85 | Peroxisome_Homo sapiens_hsa04146 | 0.53431459 |
| 86 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.53193888 |
| 87 | Long-term depression_Homo sapiens_hsa04730 | 0.51891052 |
| 88 | Thyroid cancer_Homo sapiens_hsa05216 | 0.51278413 |
| 89 | Hepatitis C_Homo sapiens_hsa05160 | 0.50830260 |
| 90 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.50257786 |
| 91 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.49781495 |
| 92 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.49770154 |
| 93 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.49699266 |
| 94 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.49076094 |
| 95 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48962070 |
| 96 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.48860244 |
| 97 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.47282811 |
| 98 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.46365202 |
| 99 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.46298952 |
| 100 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.45919796 |
| 101 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.45008298 |
| 102 | Alcoholism_Homo sapiens_hsa05034 | 0.44526316 |
| 103 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.42907110 |
| 104 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.41724516 |
| 105 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.40180920 |
| 106 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.38207586 |
| 107 | Metabolic pathways_Homo sapiens_hsa01100 | 0.37801257 |
| 108 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.36589250 |
| 109 | Morphine addiction_Homo sapiens_hsa05032 | 0.34970045 |
| 110 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.32259602 |
| 111 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.32226964 |
| 112 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.31231075 |
| 113 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30909621 |
| 114 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.30149615 |
| 115 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.28930239 |
| 116 | Bladder cancer_Homo sapiens_hsa05219 | 0.28457911 |
| 117 | Alzheimers disease_Homo sapiens_hsa05010 | 0.26877389 |
| 118 | Melanogenesis_Homo sapiens_hsa04916 | 0.26542478 |
| 119 | Lysine degradation_Homo sapiens_hsa00310 | 0.25795374 |
| 120 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.25601171 |
| 121 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.25564760 |
| 122 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.25446596 |
| 123 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.25332119 |
| 124 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.25082065 |
| 125 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.24860004 |
| 126 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.24692219 |
| 127 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.24651301 |
| 128 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.24364694 |
| 129 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.24323498 |
| 130 | Pertussis_Homo sapiens_hsa05133 | 0.24022614 |
| 131 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.23867720 |
| 132 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.23329687 |
| 133 | Salivary secretion_Homo sapiens_hsa04970 | 0.22931540 |
| 134 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.22319220 |
| 135 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.22264171 |
| 136 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.20984993 |
| 137 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.20056025 |
| 138 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.19914048 |
| 139 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.19552125 |
| 140 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.17904765 |
| 141 | Gap junction_Homo sapiens_hsa04540 | 0.17007308 |
| 142 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.16616834 |
| 143 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.16578741 |
| 144 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.16089248 |
| 145 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.15102827 |
| 146 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.15022086 |
| 147 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.13529174 |
| 148 | RNA degradation_Homo sapiens_hsa03018 | 0.13049226 |
| 149 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12605241 |
| 150 | Leishmaniasis_Homo sapiens_hsa05140 | 0.12360280 |
| 151 | Parkinsons disease_Homo sapiens_hsa05012 | 0.12127184 |
| 152 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.11901857 |
| 153 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.11760501 |
| 154 | Viral myocarditis_Homo sapiens_hsa05416 | 0.11280467 |
| 155 | Carbon metabolism_Homo sapiens_hsa01200 | 0.09976592 |
| 156 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.04061280 |
| 157 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.00384852 |

